{"rows":[{"id":112,"title":"Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization","authors":"Feliciano Yu, Joe Tafur, Francisco Moreno, Stephen Dahmer","journal":"Frontiers in Psychiatry","publication_date":"2026-05-12","publication_year":2026,"doi":"10.3389/fpsyt.2026.1777387","pubmed_id":"42233004","openalex_id":"https://openalex.org/W7161045271","source_url":"https://doi.org/10.3389/fpsyt.2026.1777387","substance_tags":"psilocybin","topic_tags":"Anxiety,Wellbeing,Observational Study,Safety,Adverse Events,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-07-04 07:00:31","bibtex":null,"source_record_id":"PMID:42233004","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1777387","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:42233004","source_url":"https://doi.org/10.3389/fpsyt.2026.1777387","doi":"10.3389/fpsyt.2026.1777387","pmid":"42233004","publication_date":"2026-05-12","importer_version":"2.1.1","text_redistributed":false}},{"id":165,"title":"Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins","authors":"Sivert Drange, Jacob Cohen, Sys Stybe Johansen, Ben Dunkley, Mikael Palner","journal":"Frontiers in Psychiatry","publication_date":"2026-04-20","publication_year":2026,"doi":"10.3389/fpsyt.2026.1819962","pubmed_id":"42094840","openalex_id":"https://openalex.org/W7155075079","source_url":"https://doi.org/10.3389/fpsyt.2026.1819962","substance_tags":"psilocybin","topic_tags":"OCD,Chronic Pain,Mechanism of Action,Microdosing,Wellbeing,Emotional Processing,Case Report,Observational Study,Toxicity","study_type":"Case Report","source_name":"OpenAlex","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-07-04 07:00:31","bibtex":null,"source_record_id":"PMID:42094840","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1819962","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:42094840","source_url":"https://doi.org/10.3389/fpsyt.2026.1819962","doi":"10.3389/fpsyt.2026.1819962","pmid":"42094840","publication_date":"2026-04-20","importer_version":"2.1.1","text_redistributed":false}},{"id":315,"title":"High hopes? Precision psychedelic addiction medicine","authors":"Rayyan Raja Zafar, Patrick Kleine, Danielle L. Kurtin, Matthew B. Wall, David Erritzoe","journal":"Frontiers in Psychiatry","publication_date":"2026-01-27","publication_year":2026,"doi":"10.3389/fpsyt.2025.1681795","pubmed_id":"41684524","openalex_id":"https://openalex.org/W7125975363","source_url":"https://doi.org/10.3389/fpsyt.2025.1681795","substance_tags":"psilocybin","topic_tags":"Addiction,Neuroplasticity,Brain Imaging,Pharmacology,Biomarkers,Aging,Emotional Processing,Clinical Trial,Review Article,Cancer Patients,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-07-04 07:00:32","bibtex":null,"source_record_id":"PMID:41684524","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2025.1681795","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:41684524","source_url":"https://doi.org/10.3389/fpsyt.2025.1681795","doi":"10.3389/fpsyt.2025.1681795","pmid":"41684524","publication_date":"2026-01-27","importer_version":"2.1.1","text_redistributed":false}},{"id":399,"title":"Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis","authors":"T. H. W. Ching, B. Stahnke, S. Shnayder, G. Agin-Liebes, T. G. Adams, L. Amoroso, O. Baiz, A. Belser, C. Bohner, M. Burke, E. D’Amico, G. DePalmer, J. Eilbott, G. Fram, R. Grazioplene, J. Hokanson, A. Jankovsky, S. A. Kichuk, B. Martins, P. Purohit, H. Schaer, Y. P. Sierra, C. Witherow, C. Pittenger, B. Kelmendi","journal":"Frontiers in Psychiatry","publication_date":"2025-12-09","publication_year":2025,"doi":"10.3389/fpsyt.2025.1726818","pubmed_id":"41450831","openalex_id":"https://openalex.org/W7113899315","source_url":"https://doi.org/10.3389/fpsyt.2025.1726818","substance_tags":"psilocybin","topic_tags":"OCD,Chronic Pain,Mechanism of Action,Emotional Processing,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-07-04 07:00:32","bibtex":null,"source_record_id":"PMID:41450831","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2025.1726818","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:41450831","source_url":"https://doi.org/10.3389/fpsyt.2025.1726818","doi":"10.3389/fpsyt.2025.1726818","pmid":"41450831","publication_date":"2025-12-09","importer_version":"2.1.1","text_redistributed":false}},{"id":4312,"title":"Psychedelic minimalism: the case against music in psychedelic therapy settings","authors":"Samir A Nader","journal":"Frontiers in Psychiatry","publication_date":"2025-08-25","publication_year":2025,"doi":"10.3389/fpsyt.2025.1652568","pubmed_id":"40933801","openalex_id":"https://openalex.org/W4413614435","source_url":"https://doi.org/10.3389/fpsyt.2025.1652568","substance_tags":"psilocybin","topic_tags":"Anxiety,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Safety,Drug Interactions","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"PMID:40933801","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2025.1652568","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:40933801","source_url":"https://doi.org/10.3389/fpsyt.2025.1652568","doi":"10.3389/fpsyt.2025.1652568","pmid":"40933801","publication_date":"2025-08-25","importer_version":"2.1.1","text_redistributed":false}},{"id":571,"title":"Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat","authors":"Grace Blest-Hopley, Giuseppe Pasculli, Simon Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M. Pate, Hannes Kettner, Leor Roseman, David Erritzøe, Robin Carhart-Harris","journal":"Frontiers in Psychiatry","publication_date":"2025-08-05","publication_year":2025,"doi":"10.3389/fpsyt.2025.1594307","pubmed_id":"40842948","openalex_id":"https://openalex.org/W4413002573","source_url":"https://doi.org/10.3389/fpsyt.2025.1594307","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Emotional Processing,Veterans,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"PMID:40842948","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2025.1594307","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:40842948","source_url":"https://doi.org/10.3389/fpsyt.2025.1594307","doi":"10.3389/fpsyt.2025.1594307","pmid":"40842948","publication_date":"2025-08-05","importer_version":"2.1.1","text_redistributed":false}},{"id":575,"title":"Therapeutic and legal aspects of psilocybin in cancer-related depression","authors":"Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska","journal":"Frontiers in Psychiatry","publication_date":"2025-08-03","publication_year":2025,"doi":"10.3389/fpsyt.2025.1591864","pubmed_id":"40831528","openalex_id":"https://openalex.org/W4412939048","source_url":"https://doi.org/10.3389/fpsyt.2025.1591864","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"PMID:40831528","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2025.1591864","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:40831528","source_url":"https://doi.org/10.3389/fpsyt.2025.1591864","doi":"10.3389/fpsyt.2025.1591864","pmid":"40831528","publication_date":"2025-08-03","importer_version":"2.1.1","text_redistributed":false}},{"id":4404,"title":"Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization","authors":"Jennifer Jones","journal":"Frontiers in Psychiatry","publication_date":"2025-04-07","publication_year":2025,"doi":"10.3389/fpsyt.2025.1565852","pubmed_id":"40264517","openalex_id":"https://openalex.org/W4409274889","source_url":"https://doi.org/10.3389/fpsyt.2025.1565852","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Animal Study,Veterans,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"PMID:40264517","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2025.1565852","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:40264517","source_url":"https://doi.org/10.3389/fpsyt.2025.1565852","doi":"10.3389/fpsyt.2025.1565852","pmid":"40264517","publication_date":"2025-04-07","importer_version":"2.1.1","text_redistributed":false}},{"id":928,"title":"Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use","authors":"Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven M. Albert, Krista J. Siefried, Jeffrey Guss","journal":"Frontiers in Psychiatry","publication_date":"2024-12-05","publication_year":2024,"doi":"10.3389/fpsyt.2024.1490907","pubmed_id":"39713770","openalex_id":"https://openalex.org/W4405122998","source_url":"https://doi.org/10.3389/fpsyt.2024.1490907","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Case Report,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-07-04 07:00:34","bibtex":null,"source_record_id":"PMID:39713770","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1490907","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:39713770","source_url":"https://doi.org/10.3389/fpsyt.2024.1490907","doi":"10.3389/fpsyt.2024.1490907","pmid":"39713770","publication_date":"2024-12-05","importer_version":"2.1.1","text_redistributed":false}},{"id":4524,"title":"Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics","authors":"Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak","journal":"Frontiers in Psychiatry","publication_date":"2024-11-05","publication_year":2024,"doi":"10.3389/fpsyt.2024.1485337","pubmed_id":"39568756","openalex_id":"https://openalex.org/W4404119543","source_url":"https://doi.org/10.3389/fpsyt.2024.1485337","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Neurogenesis,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Emotional Processing,Mystical Experience,Review Article,Observational Study,Animal Study,Healthy Volunteers,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions,Inflammation,Immune Function","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:42","last_checked":"2026-07-04 07:00:34","bibtex":null,"source_record_id":"PMID:39568756","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1485337","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:39568756","source_url":"https://doi.org/10.3389/fpsyt.2024.1485337","doi":"10.3389/fpsyt.2024.1485337","pmid":"39568756","publication_date":"2024-11-05","importer_version":"2.1.1","text_redistributed":false}},{"id":1076,"title":"Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report","authors":"André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent","journal":"Frontiers in Psychiatry","publication_date":"2024-07-15","publication_year":2024,"doi":"10.3389/fpsyt.2024.1394962","pubmed_id":"39086732","openalex_id":"https://openalex.org/W4400695899","source_url":"https://doi.org/10.3389/fpsyt.2024.1394962","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Headache / Migraine,Pharmacology,Receptor Pharmacology,Clinical Trial,Case Report,Safety,Adverse Events,Drug Interactions","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:35","bibtex":null,"source_record_id":"PMID:39086732","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1394962","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:39086732","source_url":"https://doi.org/10.3389/fpsyt.2024.1394962","doi":"10.3389/fpsyt.2024.1394962","pmid":"39086732","publication_date":"2024-07-15","importer_version":"2.1.1","text_redistributed":false}},{"id":1100,"title":"Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension","authors":"Grant Jones, Jocelyn A. Ricard, Matthew K. Nock","journal":"Frontiers in Psychiatry","publication_date":"2024-06-23","publication_year":2024,"doi":"10.3389/fpsyt.2024.1169686","pubmed_id":"38979507","openalex_id":"https://openalex.org/W4399977372","source_url":"https://doi.org/10.3389/fpsyt.2024.1169686","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Observational Study,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:35","bibtex":null,"source_record_id":"PMID:38979507","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1169686","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38979507","source_url":"https://doi.org/10.3389/fpsyt.2024.1169686","doi":"10.3389/fpsyt.2024.1169686","pmid":"38979507","publication_date":"2024-06-23","importer_version":"2.1.1","text_redistributed":false}},{"id":1110,"title":"Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder","authors":"Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz","journal":"Frontiers in Psychiatry","publication_date":"2024-06-10","publication_year":2024,"doi":"10.3389/fpsyt.2024.1406888","pubmed_id":"38919636","openalex_id":"https://openalex.org/W4399572299","source_url":"https://doi.org/10.3389/fpsyt.2024.1406888","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:35","bibtex":null,"source_record_id":"PMID:38919636","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1406888","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38919636","source_url":"https://doi.org/10.3389/fpsyt.2024.1406888","doi":"10.3389/fpsyt.2024.1406888","pmid":"38919636","publication_date":"2024-06-10","importer_version":"2.1.1","text_redistributed":false}},{"id":1111,"title":"Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”","authors":"Julia Bornemann, James B. Close, Kirran Ahmad, Tommaso Barba, Kate Godfrey, Lauren Macdonald, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"Frontiers in Psychiatry","publication_date":"2024-06-03","publication_year":2024,"doi":"10.3389/fpsyt.2024.1320780","pubmed_id":"38983371","openalex_id":"https://openalex.org/W4399334341","source_url":"https://doi.org/10.3389/fpsyt.2024.1320780","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial,Observational Study,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:35","bibtex":null,"source_record_id":"PMID:38983371","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1320780","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38983371","source_url":"https://doi.org/10.3389/fpsyt.2024.1320780","doi":"10.3389/fpsyt.2024.1320780","pmid":"38983371","publication_date":"2024-06-03","importer_version":"2.1.1","text_redistributed":false}},{"id":1164,"title":"Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress","authors":"Julia R. Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola, Diana P. English, Kristopher Kaliebe","journal":"Frontiers in Psychiatry","publication_date":"2024-04-17","publication_year":2024,"doi":"10.3389/fpsyt.2024.1301960","pubmed_id":"38699449","openalex_id":"https://openalex.org/W4394924908","source_url":"https://doi.org/10.3389/fpsyt.2024.1301960","substance_tags":"psilocybin","topic_tags":"Anxiety,End-of-Life Distress,Chronic Pain,Wellbeing,Observational Study,Healthcare Workers,Safety,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:35","bibtex":null,"source_record_id":"PMID:38699449","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1301960","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38699449","source_url":"https://doi.org/10.3389/fpsyt.2024.1301960","doi":"10.3389/fpsyt.2024.1301960","pmid":"38699449","publication_date":"2024-04-17","importer_version":"2.1.1","text_redistributed":false}},{"id":1219,"title":"Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey","authors":"Nicolas G. Glynos, Jacob S. Aday, Daniel J. Kruger, Kevin F. Boehnke, Stephanie Lake, Philippe Lucas","journal":"Frontiers in Psychiatry","publication_date":"2024-02-21","publication_year":2024,"doi":"10.3389/fpsyt.2024.1349565","pubmed_id":"38455520","openalex_id":"https://openalex.org/W4392055224","source_url":"https://doi.org/10.3389/fpsyt.2024.1349565","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 06:34:44","bibtex":null,"source_record_id":"PMID:38455520","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1349565","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38455520","source_url":"https://doi.org/10.3389/fpsyt.2024.1349565","doi":"10.3389/fpsyt.2024.1349565","pmid":"38455520","publication_date":"2024-02-21","importer_version":"2.1.1","text_redistributed":false}},{"id":4677,"title":"Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach","authors":"Phil Wolfson, Gita Vaid","journal":"Frontiers in Psychiatry","publication_date":"2024-01-31","publication_year":2024,"doi":"10.3389/fpsyt.2024.1209419","pubmed_id":"38362026","openalex_id":"https://openalex.org/W4391444130","source_url":"https://doi.org/10.3389/fpsyt.2024.1209419","substance_tags":"psilocybin","topic_tags":"Depression,Consciousness,Clinical Trial,Adverse Events","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-07-04 06:34:44","bibtex":null,"source_record_id":"PMID:38362026","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2024.1209419","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38362026","source_url":"https://doi.org/10.3389/fpsyt.2024.1209419","doi":"10.3389/fpsyt.2024.1209419","pmid":"38362026","publication_date":"2024-01-31","importer_version":"2.1.1","text_redistributed":false}},{"id":1261,"title":"Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings","authors":"Terence H. W. Ching, Lucia Amoroso, Calvin Bohner, Elizabeth J. D’Amico, Jeffrey Eilbott, Tara Entezar, Madison Fitzpatrick, Geena Fram, Rachael Grazioplene, Jamila Hokanson, Anastasia Jankovsky, Stephen A. Kichuk, Bradford Martins, Prerana Patel, Henry Schaer, Sarah Shnayder, Chelsea Witherow, Christopher Pittenger, Benjamin Kelmendi","journal":"Frontiers in Psychiatry","publication_date":"2024-01-08","publication_year":2024,"doi":"10.3389/fpsyt.2023.1278823","pubmed_id":"38264632","openalex_id":"https://openalex.org/W4390753253","source_url":"https://doi.org/10.3389/fpsyt.2023.1278823","substance_tags":"psilocybin","topic_tags":"OCD,Chronic Pain,Pharmacology,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:36","bibtex":null,"source_record_id":"PMID:38264632","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2023.1278823","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38264632","source_url":"https://doi.org/10.3389/fpsyt.2023.1278823","doi":"10.3389/fpsyt.2023.1278823","pmid":"38264632","publication_date":"2024-01-08","importer_version":"2.1.1","text_redistributed":false}},{"id":1262,"title":"In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin","authors":"N. Jones, Laura M. Wagner, Molly C. Pellitteri Hahn, Cameron O. Scarlett, Cody J. Wenthur","journal":"Frontiers in Psychiatry","publication_date":"2024-01-07","publication_year":2024,"doi":"10.3389/fpsyt.2023.1303365","pubmed_id":"38264637","openalex_id":"https://openalex.org/W4390665254","source_url":"https://doi.org/10.3389/fpsyt.2023.1303365","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Mechanism of Action,Animal Study,Toxicity","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:36","bibtex":null,"source_record_id":"PMID:38264637","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2023.1303365","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38264637","source_url":"https://doi.org/10.3389/fpsyt.2023.1303365","doi":"10.3389/fpsyt.2023.1303365","pmid":"38264637","publication_date":"2024-01-07","importer_version":"2.1.1","text_redistributed":false}},{"id":1312,"title":"Group psychedelic therapy: empirical estimates of cost-savings and improved access","authors":"Elliot Marseille, Christopher S. Stauffer, Manish Agrawal, Paul Thambi, Kimberly Roddy, Michael C. Mithoefer, Stefano Bertozzi, James G. Kahn","journal":"Frontiers in Psychiatry","publication_date":"2023-12-05","publication_year":2023,"doi":"10.3389/fpsyt.2023.1293243","pubmed_id":"38125286","openalex_id":"https://openalex.org/W4389392873","source_url":"https://doi.org/10.3389/fpsyt.2023.1293243","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Chronic Pain,Healthcare Workers,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-04 07:00:36","bibtex":null,"source_record_id":"PMID:38125286","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2023.1293243","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38125286","source_url":"https://doi.org/10.3389/fpsyt.2023.1293243","doi":"10.3389/fpsyt.2023.1293243","pmid":"38125286","publication_date":"2023-12-05","importer_version":"2.1.1","text_redistributed":false}}],"total":47,"page":1,"per_page":20,"pages":3,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Frontiers in Psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}